Greetings! 

SoCalBio Weekly Update

Past Weekly
Updates

Cut Cost of Doing Business

Join the SoCalBio Group Purchasing Program to enjoy significant savings on medical and industrial gas from

  

Click here to learn more

For more info, call SoCalBio at 

800-418-7079 ext 3 

SoCalBio Partners

 

 

vince 

 

 

 

 

vince 

 

  NP 

 

vince 

Replenish, Inc. 

airgas  

 

 

 

 

vince 

 

onelambda 

 SoCalBio Mast  

 

 

 

trinet 

onelambda

officedepot

 

Join SoCalBio
Join SoCalBio leaders to promote the biotech and device industries in Los Angeles, Orange County and neighboring communities for job creation and overall economic growth.
Become a Member
Thanks to SoCalBio Media Partners


Oct. 10,  2013


Editor: Ahmed Enany 
President & CEO
Southern California
Biomedical Council

enany@socalbio.org

www.socalbio.org

Featuring Next Gen. Medtech, Biotech & eHealth Companies
To sponsor or make a business presentation, contact SoCalBio at
800-418-7079 ext 1  -- scbc@socalbio.org

Who Is Presenting

Our target is to select and showcase 40 emerging bioscience technologies and companies during the 2013 SoCalBio Investor & Partnership Conference. Here is a partial list of companies selected to make business presentations:

 

  • Amicrobe (An advanced biomaterials company with innovative product candidates designed to prevent and treat infections)

     

  • Applied Biomedical (High accuracy disposable ambulatory infusion pump)

  • AQCI (Automated quality control instruments for nuclear pharmacies)

  • Asta Fluidic Technologies (Fetomaternal hemorrhage diagnosis)

  • BestDose (Software to personalize medication dosage)

  • Bone Rad Therapeutics (Treating tumors in bone)

  • Bruin Biometrics (Provides wireless solutions for wound care, orthopedic care, real-time data capture, analytics and reporting)

  • CaliCast (UCLA orthopedic cast technology)

  • DPS Health (Provides patients with cost-effective behavioral change and self-management support programs)

  • Dr. Marion Digital (Online apps to empower elderly care)

  • Hillhurst Biopharmaceuticals (Orally-delivered therapeutic for sickle cell disease)

  • LA BioMed technology for treating Mucormycosis

  • Perimeter Medical Imaging (Provides surgeons with real time, actionable information about tumor margins)
  • Otokinetics (Hearing implant for profound and severe hearing loss)

  • QT Medical (LA BioMed spinoff developing pediatric devices)

  • RTime.com (A one-stop solution for those seeking quality eldercare services, facilities and information)

  • Skymedicus (Provides a telemedicine platform to enable medical tourism)

  • SnapMD (A telemedicine company that provides a  communications platform tailored for pediatrics)

  • StemVax (developing the next-generation immunotherapy platform to treat brain cancer)

  • Supervision (Real-­time telesurgery)

  • SynTouch (Biomimetic tactile sensing)

  • Sentire Medical Systems (Bowel perforation sensor)

  • Trend Shift  (A health care data analytics company)

  • UCLA device for precise breast radiotherapy

  • Val 9000 (A telemedicine platform to provide voice activated access to clinical information and patient monitoring systems) 

  • Videris (Novel ultrasound-based devices for cardiovascular applications)

  • ZD Medical (Devices for vascular imaging)
  • .......... More to be announced 
  • SoCalBio Mixer
    Coming on October 29 at the Jonathan Club
    in Downtown Los Angeles
    SoCalBio Seminar and Mixer on
    "Doing Business in Canada"
     Tuesday, October 29, 2013 from 5:00 PM to 7:00 PM
    Jonathan Club in Downtown Los Angeles
    This is a complimentary event but registration is a MUST
      
    Eventbrite - Doing Business In Canada Seminar and Mixer

     

    SoCalBio is pleased to partner with the Consulate General of Canada in Los Angeles to offer this seminar on doing business in Canada. This seminar will deliver an up-to-date overview on key areas of consideration to help ensure your business has a successful entry into the Canadian marketplace. This seminar will be relevant to companies within the Entertainment, Life Sciences, IT, Clean Technology and Defense industry sectors.

      
    Agenda

    5:00 pm - 6:00 pm | Seminar 

    6:00 pm - 7:30 pm | Cocktail Reception

    New SoCalBio Members
    Dr. Marion Digital (Torrance)

    Dr. Marion Digital is a telehealth company that provides tools and other online applications to empower elderly care ... Learn more 

    Other Recent Members 

    Join SoCalBio Now 

    Med Device Tax
    Why Legions of Dentists Are Lobbying Against the 
    Medical Device Tax
     
    doctors-nurses2.jpg

    Dentists, along with hospitals, nursing homes, and insurers, have been worried that they will end up paying for the medical-device tax. In talking points given to dentists this year to raise when talking with their members of Congress and senators, the ADA said:

    "The tax will increase the cost of dental care by $160 million annually ... Medical device manufacturers, producers and importers are passing the increased cost on to dental providers. While patients may see treatment fees increase as a result of the tax, much of the cost will be borne by dentists due to the nature of dental insurance" ... Read more

    Crowdfunding
    Be Part of Applied Integrin Sciences'
    Quest to Conquer Ovarian Cancer 
     Applied Integrin Sciences, Inc. announced it launched its first crowdfunding campaign to raise funding to accelerate the development of its cancer-fighting drug that is planned to boost the survival and quality of life for patients with ovarian cancer, breast cancer, prostate cancer, and other cancers, an initiative facilitated by the Alfred E. Mann Institute for Biomedical Engineering at the University of Southern California; Three Two One Productions; When You Wish; and the women who share their ovarian cancer experiences .... Read more 
     
    Psoriasis
    Amgen And AstraZeneca Highlight Data To Be Presented At 22nd Congress Of The European Academy Of Dermatology And Venereology
     

    Amgen and AstraZeneca are collaborating in developing brodalumab, a human monoclonal antibody -- to target interleukin-17 (IL-17) receptor for treating moderate to severe psoriasis. "The Phase 2 data demonstrate that the primary and secondary end points were met, including many patients achieving and maintaining total skin clearance with continued brodalumab therapy," said Sean E. Harper, M.D., executive vice president of Research and Development at Amgen. "We look forward to further investigating brodalumab for patients with moderate to severe psoriasis" ... Read More 

    Sponsored Events
     
    November 11 - 13  in Beijing, China
    Funding
    Kythera Biopharmaceuticals Seeks to Raise
    $100 Million in a Follow-on Offering
     
    The Calabasas-based KYTHERA Biopharmaceuticals announced it has commenced an underwritten public offering of shares of its common stock to raise aggregate proceeds of $100 million.KYTHERA intends to use the net proceeds of the offering to fund the ongoing development and preparation for potential commercialization of ATX-101, including the preparation and submission of its New Drug Application, or NDA, for ATX-101, and the balance for working capital and general corporate purposes, including research and development ... Read more 
    Hepatitis B
    Arrowhead Completes Enrollment in Phase 1 Study of ARC-520 for the Treatment of Chronic Hepatitis B
     
     
    The Pasadena-based Arrowhead Research announced that it completed enrollment in a Phase 1 clinical trial of ARC-520, its RNAi-based candidate against chronic hepatitis B virus infection. Initial data indicate that ARC-520 is generally safe and well tolerated at all six dose levels studied, enabling the company to proceed with plans to initiate a Phase 2a pilot efficacy study in chronic HBV patients .... Read more 
    Oncology
    Puma Biotechnology Initiates Phase II Trial of PB272 (Neratinib) in HER2 Mutation-Positive Solid Tumor Patients
     
    The Los Angeles-based Puma announced that its Phase II basket trial will be an open-label, multicenter, multinational study to evaluate the safety and efficacy of PB272 administered daily to patients who have solid tumors with activating HER2 mutations. The study will initially include 6 cohorts (baskets) of patients, each of which will include one of the following cancers: (1) bladder/urinary tract cancer; (2) colorectal cancer; (3) endometrial cancer; (4) gastric/esophageal cancer; (5) ovarian cancer; and (6) all other solid tumors (including prostate, melanoma and pancreatic cancer) .... Read more 

    SoCalBio Group Purchasing Program
    SoCalBio is pleased to announce the addition of the following  two vendors to its growing Group Purchasing Program:

    ShareVault, a leading provider of highly secure and controlled document sharing solutions and virtual data rooms (VDR), has aligned with SoCalBio to provide companies with significant discounted pricing and complimentary extra features. ShareVault's VDR platform is optimized for life science companies of all sizes and flexibly priced so that even small biotech companies can afford and benefit from its technology. The ShareVault solution is intended for due diligence required during bio-pharma partnering, licensing, fundraising, M&A, clinical study management or other applications that require secure sharing of documents with third parties ... Learn more  

    SoCalBio has partnered with Corporate Traveler (CT) -- a leading US business travel management specialist -- to offer members a customized service approach to corporate travel encompassing all of the following services:

    • All corporate travel reservations
    • Travel planning services including health, visa and security
    • Travel Policy compliance support
    • Negotiated supplier program support
    • Online fulfillment
    • VIP travel services
    • Service Level Agreement for all Clients .. Learn more
    Join SoCalBio

    Become a SoCalBio Member and Save Money by Utlizing the SoCalBio Group Purchasing Program

    Jobs Available
    Boston Scientific Neuromodulation (Santa Clarita)

    Response Genetics (Los Angeles)

    ChromoLogic (Pasadena)

    Second Sight Medical Products (Sylmar)

    Alfred Mann Foundation for Scientific 

    Research (Santa Clarita)

    Bioness (Santa Clarita)

    Puma Biotechnology (Los Angeles)  

    About SoCalBio 
     
    SoCalBio membership links you to partners, contract manufacturers, regulatory and legal experts, and policy makers. The organization's programs help emerging biotech and medical device companies grow. Membership is affordable -- as low as $500 -- and offers access to networking opportunities, advocacy, discounts through our group purchasing program group purchasing program and other benefits you simply can't find elsewhere ... Join SoCalBio